Abstract

Current state and future prospects of pharmacological interventions for autism

Author(s): Arshya Vahabzadeh, David Buxton, Christopher J McDougle, Kimberly A Stigler

Autism spectrum disorder (ASD) is a group of heterogeneous developmental disorders manifesting in early childhood. They are associated with a range of core and associated symptoms, including repetitive behaviors, hyperactivity and irritability. This review will describe the current evidence for psychopharmacological management of individuals with ASD. Additionally, some of the future treatment prospects will be discussed. Safety issues, adverse effects and limitations of the current literature will also be highlighted.